0000950170-24-003464.txt : 20240109
0000950170-24-003464.hdr.sgml : 20240109
20240109185046
ACCESSION NUMBER: 0000950170-24-003464
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robertson Jenny
CENTRAL INDEX KEY: 0001995009
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 24524475
MAIL ADDRESS:
STREET 1: C/O LEXEO THERAPEUTICS, INC.
STREET 2: 345 PARK AVENUE SOUTH, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001907108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 854012572
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 547-9879
MAIL ADDRESS:
STREET 1: 345 PARK AVENUE SOUTH
STREET 2: FLOOR 6
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
ownership.xml
4
X0508
4
2024-01-05
false
0001907108
Lexeo Therapeutics, Inc.
LXEO
0001995009
Robertson Jenny
C/O LEXEO THERAPEUTICS, INC.
345 PARK AVENUE SOUTH, FLOOR 6
NEW YORK
NY
10010
false
true
false
false
Chief Legal and Admin Officer
true
Common Stock
2024-01-05
4
A
false
23750
0
A
23750
D
Stock Option (Right to Buy)
14.48
2024-01-05
4
A
false
142500
0
A
2034-01-04
Common Stock
142500
142500
D
The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.
25% of the shares underlying the option shall vest on January 5, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.
/s/ Jenny Robertson
2024-01-09